| Margins | Rite Bite Max Protein achieved nearly double-digit EBITDA margin. |
|---|---|
| Demand visibility | Rural demand outpacing urban recovery; steady overall trend. |
| Management confidence | High; citing market share gains and successful new launches. |
Growth
Double-digit growth in Everyuth, Nutralite, and Sugar Free Green; Complan achieved near double-digit growth despite a 4.8% category decline.
Outlook
Focus on scaling RTD hydration, expanding protein portfolios, and driving rural demand recovery via distribution expansion.
Risks
Seasonal headwinds impacted Glucon-D and Nycil; divergent commodity pricing and global geopolitical pressures on supply chains continue.
Earnings Call filed with NSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.
Zydus Wellness Ltd: key numbers
- Share price
- ₹520.60
- Market cap
- ₹16,563 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 88.0×Sector 43.4×
- Promoter holding
- 69.64%+0.01% QoQ
- FII holding
- 3.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Management Change
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has received an ESG score of 71.7 from SES ESG Research Pvt. Ltd., improving from the previous score of 70.
Zydus Wellness Annual General Meeting
Zydus Wellness Limited has filed the transcript of its 32nd Annual General Meeting held on August 4, 2026. This document records the proceedings of the meeting.
Zydus Wellness Earnings Call Transcript: Key Takeaways
Zydus reported 66.7% revenue growth, heavily distorted by the Complan (ComfortClick) acquisition. Organic performance was mixed as seasonal brands faced weather headwinds while personal care and international segments showed strong double-digit momentum.
Zydus Wellness Investor Presentation: Key Takeaways
Zydus Wellness Q1 FY27 earnings presentation highlights strong double-digit growth in core portfolios like Sugar Free and Everyuth, despite weather-related headwinds impacting seasonal brands like Glucon-D and Nycil.